Risk of first ischaemic stroke and use of antidopaminergic antiemetics: nationwide case-time-control study.
Anne Bénard-LaribièreEmilie HucteauStéphanie DebetteJulien KirchgesnerJulien BezinAntoine ParientePublished in: BMJ (Clinical research ed.) (2022)
Using French nationwide exhaustive reimbursement data, this self-controlled study reported an increased risk of ischaemic stroke with recent ADA use. The highest increase was found for metopimazine and metoclopramide.